T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein.
Laurent J, Touvrey C, Gillessen S, Joffraud M, Vicari M, Bertrand C, Ongarello S, Liedert B, Gallerani E, Beck J, Omlin A, Sessa C, Quaratino S, Stupp R, Gnad-Vogt US, Speiser DE.
Laurent J, et al. Among authors: gillessen s.
J Transl Med. 2013 Jan 7;11:5. doi: 10.1186/1479-5876-11-5.
J Transl Med. 2013.
PMID: 23294527
Free PMC article.